699 filings
Page 5 of 35
8-K
moa8h5du
7 Sep 16
Repros Provides Phase 2 Results Showing Positive Outcomes for Oral Proellex® in Women With Moderate to Severe Endometriosis
12:00am
8-K
kqckb2yq
18 Aug 16
Regulation FD Disclosure
12:00am
8-K
jac0g3jp ai300
15 Aug 16
Repros Provides Six Month Interim Results for Enclomiphene Study in Obese Secondary Hypogonadal Men
12:00am
424B5
kh6 1oiqhuvjxsp33w
9 Aug 16
Prospectus supplement for primary offering
12:00am
8-K
a9r8q52a1 3ulqv
9 Aug 16
Other Events
12:00am
8-K
vesmx1h sk
9 Aug 16
Repros Therapeutics Inc.® Reports Second Quarter 2016 Financial Results
12:00am
8-K
1h1zkj4c
19 Jul 16
Enclomiphene ( EnCyzix ™) A Mechanistically Consistent Approach to the Treatment of Secondary Hypogonadism
12:00am
8-K
8m5r gnvt
1 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
EFFECT
0wuv6wol
23 Jun 16
Notice of effectiveness
12:00am
POS AM
hfbe1r5w14e2rhj304
14 Jun 16
Prospectus update (post-effective amendment)
12:00am
8-K
1j2f uw23xb
7 Jun 16
Regulation FD Disclosure
12:00am
8-K
220oj096bm0us y4
1 Jun 16
Regulation FD Disclosure
12:00am
8-K
g3xy i5cey
18 May 16
Repros Reports Positive Clinical Data for Oral Proellex® in Women With Severe Menstrual Bleeding Due to Uterine Fibroids
12:00am
8-K
8k9slc8jyw3vj
16 May 16
Repros Announces the Appointment of MR. Patrick Fourteau As Chairman of the Board
12:00am
8-K
t5cb6l0p h9rytso3o
10 May 16
Repros Therapeutics Inc.® Reports First Quarter 2016 Financial Results
12:00am
8-K
xd6penau0i 5iluq886
12 Apr 16
Repros Reports Positive Clinical Data for Vaginal Proellex® in Women With Severe Menstrual Bleeding Due to Uterine Fibroids
12:00am